Concepedia

Brandi M. Hudson

BM

13

Publications

643

Citations

13

H-Index

2014

Active since

Affiliations

University of California, Davis(Current)

University of California, San Francisco

Relay Therapeutics (United States)

Stanford University

Columbia University

Brandi M. Hudson is an author at University of California, Davis specializing in engineering, organic chemistry, and chemistry.

Top concepts

EngineeringChemistryOrganic ChemistryBiomolecular EngineeringNatural SciencesChemical EngineeringMedicineCatalysisPharmacologyDrug Discovery

Publications per year

2014–2024

13

Publications

13

Acylammonium Salts as Dienophiles in Diels–Alder/Lactonization Organocascades

Mikail E. Abbasov, Brandi M. Hudson, Dean J. Tantillo et al. · Journal of the American Chemical Society · 2014 · 145 citations · Full text

Novel Organocatalysts, Bioorganic Chemistry, Engineering +14

RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across <i>FGFR2</i> Alterations and Resistance Mutations

Vivek Subbiah, Vaibhav Sahai, Dejan Maglic et al. · Cancer Discovery · 2023 · 103 citations · Full text

<i>qFit-ligand</i> Reveals Widespread Conformational Heterogeneity of Drug-Like Molecules in X-Ray Electron Density Maps

Gydo C. P. van Zundert, Brandi M. Hudson, Saulo H. P. de Oliveira et al. · Journal of Medicinal Chemistry · 2018 · 67 citations · Full text

Mechanistic Studies of Copper(I)-Catalyzed 1,3-Halogen Migration

Ryan Van Hoveln, Brandi M. Hudson, Henry B. Wedler et al. · Journal of the American Chemical Society · 2015 · 56 citations · Full text

Chemical Engineering, Modern Catalysis, Mechanistic Studies +13

Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2

Heike Schönherr, Pelin Ayaz, Alexander M. Taylor et al. · Proceedings of the National Academy of Sciences · 2024 · 53 citations · Full text

Rows per page

1–5 of 13